Home › Funds › Pale Fire Capital SE › RIGL

Pale Fire Capital SE position in RIGL

RIGEL PHARMACEUTICALS INC · Health Care

Pale Fire Capital SE reported holding 11,902 shares of RIGL (RIGEL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$573K, representing 0.04% of its reported portfolio and ranking #30 among its reported holdings. Pale Fire Capital SE has disclosed RIGL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)11.90K sh
Reported value held$573.08K
Portfolio Weight0.04%
First reportedQ1 2026
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Pale Fire Capital SE's RIGL position evolved

Pale Fire Capital SE first disclosed a stake in RIGL in Q1 2026 at 14,252 shares (US$385K). The position peaked in Q3 2026 at 11,902 shares, worth US$573K. Across 3 filings, Pale Fire Capital SE increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 11,902 shares valued at US$573K — a reduction of -2,350 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 14.25K $385.37K New
Q2 2026 14.25K $557.54K Hold
Q3 2026 11.90K $573.08K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RIGL and 13F data

RIGL (RIGEL PHARMACEUTICALS INC) is a Health Care company. 45 other funds we track also report a position in RIGL — the largest reported positions include Soleus Capital Management, L.P. (US$72.1M), ARMISTICE CAPITAL, LLC (US$65.4M), CM Management, LLC (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RIGL

All RIGL fund holders →

FAQ

How long has Pale Fire Capital SE held RIGL?

Pale Fire Capital SE has disclosed RIGL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Pale Fire Capital SE's current position in RIGL?

As of Q3 2026, Pale Fire Capital SE holds 11.90K shares of RIGL (RIGEL PHARMACEUTICALS INC), valued at $573.08K, representing 0.04% of its reported portfolio and ranking #30.

Has Pale Fire Capital SE been buying or selling RIGL?

In the latest 13F filing (Q3 2026), Pale Fire Capital SE reduced its position in RIGL. The position peaked in Q3 2026 at 11.90K shares.

Which other funds hold RIGL?

Other major institutional holders of RIGL include Soleus Capital Management, L.P., ARMISTICE CAPITAL, LLC, CM Management, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.